In connection with the publication of the Interim Report for Q1 2021 on May 14, 2021, we invite you to watch an investor meeting with Krzysztof Mędrala, CEO of MedApp S.A.

20 May 2021

In connection with the publication of the Interim Report for Q1 2021 on May 14, 2021, we invite you to watch an investor meeting with Krzysztof Mędrala, CEO of MedApp S.A.

The meeting on May 17, 2021 was held by the Polish Association of Individual Investors. We would like to thank Michal Maslowski for the engaging conversation.

We appreciate the presence of Investors and Partners interested in our results in the first months of this year and the Company’s plans for the next quarters of 2021.

If you have any investor questions, feel free to send them to biuro@medapp.pl

Read more See similar articles:

26 March 2024

March 22, 2024, Barcelona – MedApp begins collaboration with Renalyse on revolutionary medical device for chronic kidney disease diagnosis

On Friday, March 22, we participated in an exciting kick-off meeting for the RenaMed project in Barcelona, Spain, organized by our partners from Renalyse. The meeting was held in one of Barcelona’s most iconic locations, La Pedrera.

26 February 2024

MedApp at HIMSS24

We are very pleased to announce that MedApp SA will participate in one of the largest medical-technology fairs in the world – HIMSS24, which will be held March 11-15, 2024 in Orlando, Florida.

03 January 2024

MedApp Clinics expands range of services offered – 2023 summary.

In the past year, MedAppClinics has made significant strides in developing and expanding its range of services. A key element of the company’s strategy was the integration with five renowned medical facilities, which strengthened its competence and reach.